241 related articles for article (PubMed ID: 19258488)
1. Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein.
Chen J; Cha-Molstad H; Szabo A; Shalev A
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1133-9. PubMed ID: 19258488
[TBL] [Abstract][Full Text] [Related]
2. Preventing β-cell loss and diabetes with calcium channel blockers.
Xu G; Chen J; Jing G; Shalev A
Diabetes; 2012 Apr; 61(4):848-56. PubMed ID: 22442301
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockers act through nuclear factor Y to control transcription of key cardiac genes.
Cha-Molstad H; Xu G; Chen J; Jing G; Young ME; Chatham JC; Shalev A
Mol Pharmacol; 2012 Sep; 82(3):541-9. PubMed ID: 22734068
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyocyte-specific Txnip C247S mutation improves left ventricular functional reserve in streptozotocin-induced diabetic mice.
Mukai N; Nakayama Y; Abdali SA; Yoshioka J
Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H259-H274. PubMed ID: 34085839
[TBL] [Abstract][Full Text] [Related]
5. Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.
Myers RB; Fomovsky GM; Lee S; Tan M; Wang BF; Patwari P; Yoshioka J
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1748-59. PubMed ID: 27037370
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis.
Chen J; Saxena G; Mungrue IN; Lusis AJ; Shalev A
Diabetes; 2008 Apr; 57(4):938-44. PubMed ID: 18171713
[TBL] [Abstract][Full Text] [Related]
7. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.
Masson E; Koren S; Razik F; Goldberg H; Kwan EP; Sheu L; Gaisano HY; Fantus IG
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1251-61. PubMed ID: 19223654
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes.
Chen J; Hui ST; Couto FM; Mungrue IN; Davis DB; Attie AD; Lusis AJ; Davis RA; Shalev A
FASEB J; 2008 Oct; 22(10):3581-94. PubMed ID: 18552236
[TBL] [Abstract][Full Text] [Related]
9. Redox regulation by nuclear factor erythroid 2-related factor 2: gatekeeping for the basal and diabetes-induced expression of thioredoxin-interacting protein.
He X; Ma Q
Mol Pharmacol; 2012 Nov; 82(5):887-97. PubMed ID: 22869588
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity.
Al-Gayyar MM; Abdelsaid MA; Matragoon S; Pillai BA; El-Remessy AB
Br J Pharmacol; 2011 Sep; 164(1):170-80. PubMed ID: 21434880
[TBL] [Abstract][Full Text] [Related]
11. Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death.
Chen J; Fontes G; Saxena G; Poitout V; Shalev A
Diabetes; 2010 Feb; 59(2):440-7. PubMed ID: 19875615
[TBL] [Abstract][Full Text] [Related]
12. Lack of TXNIP protects beta-cells against glucotoxicity.
Shalev A
Biochem Soc Trans; 2008 Oct; 36(Pt 5):963-5. PubMed ID: 18793170
[TBL] [Abstract][Full Text] [Related]
13. ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy.
Chen N; Song S; Yang Z; Wu M; Mu L; Zhou T; Shi Y
J Diabetes Complications; 2021 Dec; 35(12):108050. PubMed ID: 34600826
[TBL] [Abstract][Full Text] [Related]
14. Verapamil Attenuated Prediabetic Neuropathy in High-Fat Diet-Fed Mice through Inhibiting TXNIP-Mediated Apoptosis and Inflammation.
Xu L; Lin X; Guan M; Zeng Y; Liu Y
Oxid Med Cell Longev; 2019; 2019():1896041. PubMed ID: 30733849
[TBL] [Abstract][Full Text] [Related]
15. Cytokines Regulate β-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways.
Hong K; Xu G; Grayson TB; Shalev A
J Biol Chem; 2016 Apr; 291(16):8428-39. PubMed ID: 26858253
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of thioredoxin-interacting protein and inflammasome assembly using verapamil mitigates diabetic retinopathy and pancreatic injury.
Eissa LD; Ghobashy WA; El-Azab MF
Eur J Pharmacol; 2021 Jun; 901():174061. PubMed ID: 33766618
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis.
Minn AH; Hafele C; Shalev A
Endocrinology; 2005 May; 146(5):2397-405. PubMed ID: 15705778
[TBL] [Abstract][Full Text] [Related]
19. Induction of thioredoxin-interacting protein is mediated by oxidative stress, calcium, and glucose after brain injury in mice.
Kim GS; Jung JE; Narasimhan P; Sakata H; Chan PH
Neurobiol Dis; 2012 May; 46(2):440-9. PubMed ID: 22366181
[TBL] [Abstract][Full Text] [Related]
20. A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis.
Dunn LL; Simpson PJ; Prosser HC; Lecce L; Yuen GS; Buckle A; Sieveking DP; Vanags LZ; Lim PR; Chow RW; Lam YT; Clayton Z; Bao S; Davies MJ; Stadler N; Celermajer DS; Stocker R; Bursill CA; Cooke JP; Ng MK
Diabetes; 2014 Feb; 63(2):675-87. PubMed ID: 24198286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
